Erste Asset Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Erste Asset Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-12,300	Closed	-$416K	–	534
2021 Q2	$416K	Hold	12,300	–	–	0.01%	433
2021 Q1	$288K	Hold	12,300	–	–	0.01%	431
2020 Q4	$370K	Buy	+12,300	New	+$310K	0.01%	415

Erste Asset Management's CNST Position: Q3 2021 in Review

Erste Asset Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 12,300 shares — an estimated $416K sold.

Erste Asset Management first reported a position in CNST in Q4 2020 and held it in 3 quarters. The position peaked at $416K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Erste Asset Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Erste Asset Management sold 12,300 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $416K.
Erste Asset Management first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2020 and held it in 3 quarters.
Erste Asset Management's Constellation Pharmaceuticals, Inc. position peaked at $416K in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Erste Asset Management's 13F filing for Q3 2021, filed 25 Nov 2024.